Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

More Frequent HCFA Payment, Coding Adjustments Called For In Ramstad Bill

This article was originally published in The Gray Sheet

Executive Summary

The Health Care Financing Administration would be required to adjust Medicare's payment systems annually in order to accommodate changes in medical technology, under legislation (HR 2030) introduced June 7 by Rep. Jim Ramstad (R-Minn.).
Advertisement

Related Content

Exogen Avoids Lengthy MCAC Process In HCFA Coverage Review
Exogen Avoids Lengthy MCAC Process In HCFA Coverage Review
Lab Test Payment Language Added To Medicare Technology Access Bill
Lab Test Payment Language Added To Medicare Technology Access Bill
Rep. Ramstad Nearly Ready To Unveil Y2K Version Of Medicare Legislation
Rep. Ramstad Nearly Ready To Unveil Y2K Version Of Medicare Legislation
HIMAPAC Coffers Reaches $16,000; Funds Flow To 20 Candidates As Of Feb. 1
HIMAPAC Coffers Reaches $16,000; Funds Flow To 20 Candidates As Of Feb. 1
Advertisement
UsernamePublicRestriction

Register

MT011914

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel